Clinical Trials

Discussing the finer points of AI as a catalyst for pharmaceutical innovation

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.

Older adults are underrepresented in clinical trials. This needs to change.

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them

A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials.

Experts consider how decentralized clinical trials will change in the future